VAV to support academic research in lipid nanomedicine
The company has announced a slew of research benefits to universities and academic institutions around the world that take up…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
NDDS
VAV expands capacity for COVID-19 lipids
The company invests Rs 15 crores to boost capacity to meet overseas demand for specialised lipids used in COVID-19 vaccines and…
MSU organises international conference on NDDS
The conference was held to pay a tribute to the contribution of Late Professor A N Misra as an academician and researcher par…
From HIV to COVID-19: The role of liposomal nanotechnology as an NDDS of choice
Arun Kedia, Managing Director, VAV Life Sciences, elaborates how NDDS have proved to be beneficial with applications across…
Drugs & Cosmetics Act, 1940: Recommendations for a revamp
The existing Drugs and Cosmetics Act of 1940 was formed during the pre-independence era. Since then, amendments have been made to…